
Ampx-wt
Industrials · USD
Price
$16.92
Cap
$2.3B
Earnings
4/4 beat
30d Trend
+1%
Near 52-week highs — limited upside before resistance
Target range: $18 – $22 (consensus: $20)
Consensus: Strong Buy
Earnings history
Q4 2025
BEAT
-0.01 vs -0.04
Q3 2025
BEAT
-0.03 vs -0.06
Q2 2025
BEAT
-0.05 vs -0.08
Q1 2025
BEAT
-0.08 vs -0.09
Key macro factors
Transition to Electric Mobility & Advanced Battery Demand: Global efforts to reduce carbon emissions and the increasing adoption of electric vehicles, unmanned aerial systems, and other electric mobility solutions directly drive demand for high-energy-density batteries like those produced by Amprius. This trend is amplified by high oil prices, making alternatives more attractive. Global inflation could, however, increase manufacturing costs.
Government Defense Spending and Domestic Supply Chains: Increased defense budgets, particularly in the US (like the proposed $1.5 trillion defense budget), create significant opportunities for Amprius as its silicon-anode batteries are critical for defense and aerospace applications such as drones. The focus on domestic manufacturing partnerships also aligns with national security priorities and reduces reliance on foreign supply chains.
Inflationary Pressures and Interest Rates: While higher interest rates could increase borrowing costs for expansion, the broader inflation risk, fueled by geopolitical conflicts like in the Middle East, impacts raw material costs and operational expenses. Amprius' ability to maintain strong gross margins (24% in Q4 2025) despite these pressures is key.
Amprius Technologies is a leading manufacturer of high-energy and high-capacity lithium-ion batteries, specializing in silicon anodes for high-energy-density cells used in aviation, electric vehicles, and light electric vehicles.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
